Hints and tips:
...The group has been highly acquisitive in recent years, having closed a $4.2bn buyout of FEI Company last September, and a $1.3bn deal for Affymetrix last March....
...The deal comes just months after Thermo snapped up Affymetrix for $1.3bn in a move that will help the company expand its array of laboratory equipment, which includes diagnostic tools for hospitals and mass...
...“X Inc” trades at a steep 29 times trailing earnings versus 18 for the entire index....
...In addition to Pfizer, Affymetrix, Maverick Capital, CSK Ventures, Eli Lilly and other investors have taken major stakes in Perlegen....
...Affymetrix had never imagined that there was such a big research effort in biochips in China, working to such a high standard,? says Cheng Jing, CapitalBio?s chief executive....
...In January, Roche, the Swiss drugs and diagnostics group, and Affymetrix, a US genetics company, announced US regulatory approval for the first market application for their revolutionary AmpliChip diagnostics...
...Fisher, Chairman, Gap, Inc....
International Edition